Tue Sep 17 05:52:22 UTC 2024: ## Young Woman Diagnosed with Stage 3 Pancreatic Cancer at 21, Blames COVID-19 Vaccine
**OTTAWA, CANADA** – Alexandra Angeles Caycho, a 21-year-old aspiring artist, has been given days to live after being diagnosed with Stage 3 pancreatic cancer, a rare and aggressive form of the disease for someone her age.
Caycho’s case is raising eyebrows among medical professionals and fueling concerns about a potential link to COVID-19 mRNA vaccines. Dr. William Makis, a Canadian physician with expertise in Radiology, Oncology, and Immunology, claims that the young woman’s cancer is a textbook case of “Turbo Cancer,” a term he coined to describe a more aggressive form of cancer potentially triggered by the COVID-19 vaccines.
Dr. Makis points out that pancreatic cancer is extremely rare in people under 45, and that the average age at diagnosis is 70. He attributes the potential link to the size of the mRNA vaccine particles, which he says can accumulate in the bile ducts, gallbladder, and pancreas.
While the exact mechanism remains unclear, Dr. Makis believes that the vaccines may have a localized carcinogenic effect, potentially contributing to the rapid development of cancer.
Caycho, heartbroken and facing a grim prognosis, has launched a fundraising campaign to return to her native Peru to spend her final days with her family.
The case has ignited a debate about the potential long-term side effects of COVID-19 vaccines, and Dr. Makis’s theory has been widely circulated online. However, the medical community remains largely skeptical about the “Turbo Cancer” hypothesis, urging caution against jumping to conclusions without further scientific evidence.
Global Research, a website dedicated to exploring alternative perspectives on current events, is publishing an in-depth report by Michel Chossudovsky, who outlines the potential dangers of the COVID-19 vaccine, drawing on a wide range of scientific and political sources.
This case highlights the ongoing uncertainty surrounding the long-term effects of the COVID-19 vaccines and the need for continued research and open discussion.
First Piper 